Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varithena vs Radiofrequency Ablation for Pain in Varicose Veins
NCT02462720Phase 4Completed
- Sponsor
- Boston Scientific Corporation
- Start
- May 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of polidocanol in Varicose Veins (2 arms), sponsored by Boston Scientific Corporation. Primary endpoint: Pain. Started May 2015; status: completed.
02
Drugs
polidocanol
03
Conditions
Varicose Veins
Beyond the preview
Go deeper on NCT02462720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02462720.